Rhythm Pharmaceuticals, Inc is a biotechnology business based in the US. Rhythm Pharmaceuticals shares (RYTM) are listed on the NASDAQ and all prices are listed in US Dollars. Rhythm Pharmaceuticals employs 90 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Rhythm Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RYTM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Rhythm Pharmaceuticals stock price (NASDAQ: RYTM)Use our graph to track the performance of RYTM stocks over time.
Rhythm Pharmaceuticals shares at a glance
|Latest market close||$19.61|
|52-week range||$18.00 - $43.26|
|50-day moving average||$19.87|
|200-day moving average||$24.29|
|Wall St. target price||$46.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.34|
Buy Rhythm Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Rhythm Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Rhythm Pharmaceuticals price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||-2.63%|
|3 months (2021-04-29)||-8.79%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
Rhythm Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-24.37%|
|Return on equity TTM||-17.69%|
|Market capitalisation||$973.5 million|
TTM: trailing 12 months
Shorting Rhythm Pharmaceuticals shares
There are currently 3.8 million Rhythm Pharmaceuticals shares held short by investors – that's known as Rhythm Pharmaceuticals's "short interest". This figure is 1.7% down from 3.8 million last month.
There are a few different ways that this level of interest in shorting Rhythm Pharmaceuticals shares can be evaluated.
Rhythm Pharmaceuticals's "short interest ratio" (SIR)
Rhythm Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Rhythm Pharmaceuticals shares currently shorted divided by the average quantity of Rhythm Pharmaceuticals shares traded daily (recently around 442999.17936694). Rhythm Pharmaceuticals's SIR currently stands at 8.53. In other words for every 100,000 Rhythm Pharmaceuticals shares traded daily on the market, roughly 8530 shares are currently held short.
However Rhythm Pharmaceuticals's short interest can also be evaluated against the total number of Rhythm Pharmaceuticals shares, or, against the total number of tradable Rhythm Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Rhythm Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Rhythm Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.1066% of the tradable shares (for every 100,000 tradable Rhythm Pharmaceuticals shares, roughly 107 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Rhythm Pharmaceuticals.
Find out more about how you can short Rhythm Pharmaceuticals stock.
Rhythm Pharmaceuticals share dividends
We're not expecting Rhythm Pharmaceuticals to pay a dividend over the next 12 months.
Rhythm Pharmaceuticals share price volatility
Over the last 12 months, Rhythm Pharmaceuticals's shares have ranged in value from as little as $18 up to $43.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rhythm Pharmaceuticals's is 1.4392. This would suggest that Rhythm Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Rhythm Pharmaceuticals overview
Rhythm Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015.
Stocks similar to Rhythm Pharmaceuticals
Rhythm Pharmaceuticals in the news
Rhythm Pharmaceuticals Announces Senior Leadership Additions
Rhythm Pharmaceuticals Announces Senior Leadership Additions
Rhythm Pharmaceuticals announce senior leadership additions
Frequently asked questionsWhat percentage of Rhythm Pharmaceuticals is owned by insiders or institutions?
Currently 2.984% of Rhythm Pharmaceuticals shares are held by insiders and 98.207% by institutions. How many people work for Rhythm Pharmaceuticals?
Latest data suggests 90 work at Rhythm Pharmaceuticals. When does the fiscal year end for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals's fiscal year ends in December. Where is Rhythm Pharmaceuticals based?
Rhythm Pharmaceuticals's address is: 222 Berkeley Street, Boston, MA, United States, 02116 What is Rhythm Pharmaceuticals's ISIN number?
Rhythm Pharmaceuticals's international securities identification number is: US76243J1051 What is Rhythm Pharmaceuticals's CUSIP number?
Rhythm Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 76243J105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert